Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs. (Q53486855)

14 May 2018

title

Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs. (English)

1 reference

14 May 2018

0 references

1 reference

Rozh H Al-Mashhadi

1

0 references

Martin Bødtker Mortensen

object named as

Martin B Mortensen

3

0 references

Christina Christoffersen

object named as

Christina Christoffersen

4

0 references

Jacob Fog Bentzon

object named as

Jacob F Bentzon

7

0 references

author name string

Martin M Bjørklund

2

1 reference

14 May 2018

Torben Larsen

5

1 reference

14 May 2018

Erling Falk

6

1 reference

14 May 2018

publication date

31 May 2015

1 reference

14 May 2018

published in

Diabetologia

1 reference

14 May 2018

volume

58

1 reference

14 May 2018

issue

8

1 reference

14 May 2018

page(s)

1926-1936

1 reference

14 May 2018

https://scigraph.springernature.com/pub.10.1007/s00125-015-3637-1

exact match

0 references

cites work

Type 1 diabetes and coronary artery disease

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Impaired renal function further increases odds of 6-year coronary artery calcification progression in adults with type 1 diabetes: the CACTI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Type 1 diabetes, hyperglycaemia, and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Why does diabetes increase atherosclerosis? I don't know!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Predictors of incident albuminuria in the Framingham Offspring cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Development of atherosclerosis in the diabetic BALB/c mice. Prevention with Vitamin E administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

The cis-9,trans-11 isomer of conjugated linoleic acid (CLA) lowers plasma triglyceride and raises HDL cholesterol concentrations but does not suppress aortic atherosclerosis in diabetic apoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Reduction of cardiac functional reserve and elevation of aortic stiffness in hyperlipidemic Yucatan minipigs with systemic and coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Diabetes-induced accelerated atherosclerosis in swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Akt pathway is hypoactivated by synergistic actions of diabetes mellitus and hypercholesterolemia resulting in advanced coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Increased atherosclerosis in streptozotocin-induced diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Effects of streptozotocin-induced diabetes in apolipoprotein AI deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Atherosclerotic lesions in mouse and man: is it the same disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Increased atherosclerosis in diabetic dyslipidemic swine: protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Regulation of hepatic LDL receptors by mTORC1 and PCSK9 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Association between glycosylated hemoglobin level and cardiovascular and all-cause mortality in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Is glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Intracoronary ultrasound examinations reveal significantly more advanced coronary atherosclerosis in people with type 1 diabetes than in age- and sex-matched non-diabetic controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3637-1

Studies on the energy metabolism of pig red cells. I. The limiting role of membrane permeability in glycolysis

21 January 2018

1 reference

12 December 2020

The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus

1 reference

12 December 2020

Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial

1 reference

12 December 2020

Hormonal regulation of low-density lipoprotein (LDL) receptor activity in human hepatoma Hep G2 cells. Insulin increases LDL receptor activity and diminishes its suppression by exogenous LDL

1 reference

12 December 2020

Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women

1 reference

12 December 2020

Reduced atherogenesis in cholesterol-fed diabetic rabbits. Giant lipoproteins do not enter the arterial wall

1 reference

12 December 2020

Intestinal and Hepatic Cholesterogenesis in Hypercholesterolemic Dyslipidemia of Experimental Diabetes in Dogs

1 reference

12 December 2020

Contributions of Absorbed Dietary Cholesterol and Cholesterol Synthesized in Small Intestine to Hypercholesterolemia in Diabetic Rats

1 reference

12 December 2020

Streptozotocin-induced diabetes in human apolipoprotein B transgenic mice. Effects on lipoproteins and atherosclerosis

1 reference

12 December 2020

Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice

1 reference

12 December 2020

Familial hypercholesterolemia and atherosclerosis in cloned minipigs created by DNA transposition of a human PCSK9 gain-of-function mutant

1 reference

12 December 2020

Coronary microvascular dysfunction in a porcine model of early atherosclerosis and diabetes

1 reference

12 December 2020

Glycemic Control and Excess Mortality in Type 1 Diabetes

1 reference

12 December 2020

10.1007/S00125-015-3637-1

Identifiers

DOI

1 reference

14 May 2018

PubMed ID

26026653

1 reference

14 May 2018